Abstract:Novel tetrahydrobenzo[b]thiophene derivatives (1–14) were designed as dual topoisomerase (Topo) I/II inhibitors and DNA intercalators. Compound 3 displayed superior Topo I and II inhibitory potentials (IC50 = 25.26 and 10.01 nM), whereas compound 14 showed the best DNA binding affinity (IC50 = 77.82 μM). A series of tetrahydrobenzo[b]thiophene derivatives was designed and synthesized as dual topoisomerase (Topo) I/II inhibitors implicating potential DNA intercalation. Ethyl‐2‐amino‐3‐cyano‐4,5,6,7‐tetrahydrobenzo[b]thiophene‐4‐carboxylate (1) was prepared by modification of the Gewald reaction procedure using a Fe2O3 nanocatalyst and then it was used as a building block for the synthesis of tetrahydrobenzo[b]thiophene candidates (2–14). Interestingly, compound 14 showed the best cytotoxic potential against hepatocellular, colorectal, and breast cancer cell lines (IC50 = 7.79, 8.10, and 3.53 μM), respectively, surpassing doxorubicin at breast cancer (IC50 = 4.17 μM). Meanwhile, the Topo I and II inhibition assay displayed that compound 3 could exhibit the best inhibitory potential among the investigated candidates (IC50 = 25.26 and 10.01 nM), respectively, in comparison to camptothecin (IC50 = 28.34 nM) and doxorubicin (IC50 = 11.01 nM), as reference standards. In addition, the DNA intercalation assay showed that compound 14 could display the best binding affinity with an IC50 value of 77.82 μM in comparison to doxorubicin (IC50 = 58.03 μM). Furthermore, cell cycle and apoptosis analyses described that compound 3 prompts the G1 phase arrest in michigan cancer foundation‐7 cancer cells and increases the apoptosis ratio by 29.31% with respect to untreated cells (2.25%). Additionally, the conducted molecular docking assured the promising binding of the investigated members toward Topo I and II with potential DNA intercalation. Accordingly, the synthesized compounds could be treated as promising anticancer candidates for future optimization.

Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects

Strictosidine Synthase Triggered Enantioselective Synthesis of N-Substituted (S)-3,14,18,19-tetrahydroangustines As Novel Topoisomerase I Inhibitors.

Novel Potentially Antibacterial Naphthalimide-Derived Metronidazoles: Design, Synthesis, Biological Evaluation and Supramolecular Interactions with DNA, Human Serum Albumin and Topoisomerase II

Synthesis and Antiproliferative Activity of 9-Benzylamino-6-chloro-2-methoxy-acridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors.

In Silico and In Vitro Investigation of Cytotoxicity and Apoptosis of Acridine/Sulfonamide Hybrids Targeting Topoisomerases I and II

Novel Synthetic Azaacridine Analogues As Topoisomerase 1 Inhibitors

Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties

Novel Synthetic 9-Benzyloxyacridine Analogue As Both Tyrosine Kinase and Topoisomerase I Inhibitor

Synthesis and Biological Research of Novel Azaacridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors

ChemInform Abstract: Novel Synthetic Azaacridine Analogues As Topoisomerase 1 Inhibitors.

Novel Synthetic 2-Amino-10-(3,5-dimethoxy)benzyl-9(10h)-acridinone Derivatives As Potent DNA-binding Antiproliferative Agents.

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Anilides and quinolones with nitrogen-bearing substituents from benzothiophene and thienothiophene series: synthesis, photochemical synthesis, cytostatic evaluation, 3D-derived QSAR analysis and DNA-binding properties

Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders.

Synthesis and Anticancer Research ofN-(2-aminophenyl)benzamide Acridine Derivatives as Dual Topoisomerase I and Isoform-Selective HDAC Inhibitors

Synthesis and biological evaluation of pyrazole linked benzothiazole-β-naphthol derivatives as topoisomerase I inhibitors with DNA binding ability

Study of nitrogen heterocycles as DNA/HSA binder, topoisomerase inhibitors and toxicological safety

The effects of AG1478 on expression and nuclear translocation of SOX2 via the PI3K/AKT signal pathway in non-small cell lung cancer

Design, one-pot novel synthesis of substituted acridine derivatives: DFT, structural characterisation, ADME and anticancer DNA polymerase epsilon molecular docking studies

Crystal Structures, Molecular Docking and In Vitro Investigations of Two 4-Substituted 2-(5,5-dimethyl-3-styrylcyclohex-2-enylidene)malononitrile Derivatives as Potential Topoisomerase II Inhibitors

Pharmacophore‐based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators